MedPath

Luprodex

Brand Name: Luprodex

Generic Name: Leuprorelin acetate

Active
Registration Number

DRP-7757

Dosage Form

Lyophilized Powder for Injection (IM/SC)

Issuance Date

June 20, 2022

Expiry Date

June 20, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength3.75 mg
PackagingUSP Type I Clear, Colorless Glass Vial with orange aluminium flip-off seal with USP Type I Clear Glass Ampoule containing 2 mL of diluent, 2 22G needles, 3 mL syringe and 2 alcohol swabs in a transparent PVC plastic tray in a box

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Gonadotropin Releasing Hormone (GnRH) Analogue
A
Application
Initial (Variation)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Leuprorelin acetateActive
Monograph: Leuprolide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform